Form 4: Mesa Laboratories CFO John Sakys Acquires 8,351 Restricted Stock Units
SEC Form 4 Filing
Mesa Laboratories CFO John Sakys reports the acquisition of 8,351 Restricted Stock Units (RSUs) on June 18, 2024, vesting in three annual installments.
Summary
- John Sakys, CFO of Mesa Laboratories, acquired 8,351 Restricted Stock Units (RSUs) on June 18, 2024.
- Each RSU represents a contingent right to receive one share of Mesa Laboratories' common stock.
- The RSUs vest in three equal installments, starting on June 18, 2025, and continuing on the subsequent two anniversary dates.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The acquisition of RSUs by the CFO indicates confidence in the company's future, but it's a routine transaction.
Future Outlook
The RSUs vest over a three-year period, suggesting a commitment to the company's long-term performance.
Industry Context
Acquisition of restricted stock units is a common form of executive compensation, aligning management's interests with those of shareholders.
Stakeholder Impact
- The RSU grant aligns the CFO's interests with those of shareholders, potentially encouraging decisions that increase shareholder value.
Key Dates
| Date | Description |
|---|---|
| 06/18/2024 | Date of transaction: Acquisition of 8,351 Restricted Stock Units. |
| 06/18/2025 | First vesting date for 1/3 of the Restricted Stock Units. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.